NCT06844201

Brief Summary

This retrospective study aims to investigate the effects of norepinephrine compared to ephedrine, administered on the day of surgery, on the incidence of postoperative delirium.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

February 20, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 25, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

February 19, 2025

Last Update Submit

February 19, 2025

Conditions

Keywords

EphedrineNorepinephrinePostoperative delirium

Outcome Measures

Primary Outcomes (1)

  • Postoperative delirium

    The outcome of postoperative delirium will be observed using the ICD-10 codes F05, R40, and R41 for delirium, somnolence, and disorientation, respectively.

    Within 7 days following surgery.

Study Arms (2)

Ephedrine group

This group received ephedrine on the day of surgery.

Drug: Ephedrine

Norepinephrine group

This group received norepinephrine on the day of surgery.

Drug: Norepinephrine

Interventions

Received ephedrine the same day of surgery.

Ephedrine group

Received norepinephrine the same day of surgery.

Norepinephrine group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients within the TriNetX database.

You may qualify if:

  • underwent surgery (CPT code 1003143)
  • administered ephedrine on the day of surgery

You may not qualify if:

  • received both vasopressors (ephedrine and norepinephrine) on the day of surgery.
  • patients who underwent neurology and neuromuscular surgery, cardiac surgery, and cardiac procedures
  • patients who were administered epinephrine or dopamine on the day of surgery
  • patients who were administered ephedrine or norepinephrine at any time within the 7 days following the day of surgery
  • a prior history of disorientation (ICD-10 code R41.0) or unspecified dementia (F03)
  • Norepinephrine group:
  • underwent surgery (CPT code 1003143)
  • administered norepinephrine on the day of surgery
  • received both vasopressors (ephedrine and norepinephrine) on the day of surgery.
  • patients who underwent neurology and neuromuscular surgery, cardiac surgery, and cardiac procedures
  • patients who were administered epinephrine or dopamine on the day of surgery
  • patients who were administered ephedrine or norepinephrine at any time within the 7 days following the day of surgery
  • a prior history of disorientation (ICD-10 code R41.0) or unspecified dementia (F03)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Emergence Delirium

Interventions

EphedrineNorepinephrine

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PropanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsPropanolsAminesPhenethylaminesEthylaminesEthanolaminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Coordinator

Study Record Dates

First Submitted

February 19, 2025

First Posted

February 25, 2025

Study Start

February 20, 2025

Primary Completion

June 1, 2025

Study Completion

August 1, 2025

Last Updated

February 25, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

We do not have an IPD in place at this time.